<DOC>
	<DOCNO>NCT00371098</DOCNO>
	<brief_summary>Background : Influenza vaccination recommend patient ( pt ) cardiovascular disease , however shortage clinical study prove protective effect clinical course coronary artery disease ( CAD ) . The aim study evaluate effect influenza vaccination incidence coronary event pt CAD confirm coronary angiography .</brief_summary>
	<brief_title>Influenza Vaccination Prevention From Acute Coronary Events Coronary Artery Disease - FLUCAD Study</brief_title>
	<detailed_description>A possible relation influenza high mortality cardiovascular problem first notice early nineteen hundred , epidemic Europe United States discover ( 1 ) . In last decade many study implicate important role inflammation infection ( Herpes virus , Chlamydia pneumoniae , Helicobacter pylorus ) development progression atherosclerosis ( 2,3 ) , marker inflammation like : hs-CRP , fibrinogen , become new independent cardiovascular risk factor ( 4 ) . Many general physician recommend influenza vaccination patient coronary artery disease ( CAD ) despite shortage study prove protective effect clinical course CAD . In literature find report explore hypothesis influenza vaccination might reduce incidence myocardial infarction ( MI ) acute coronary syndrome ( ACS ) . Naghavi et . retrospective , case- control study 218 patient chronic coronary disease report influenza vaccination strongly associate freedom new MI influenza season . ( OR 0.33 , 95 % CI 0.13 to0.82 , p=0.017 ) ( 5 ) . Gurfinkiel et . evaluate prospective , single- blind Fluvacs study preventive impact vaccination subsequent ischemic event 6 month follow-up . Study group consist 301 patient coronary angioplasty ( PCI ) . The first primary outcome- cardiovascular death occur 2 % vaccine group compare 8 % control group ( p=0.01 ) triple composite end point ( death , myocardial infarction hospitalization ischemia occur 11 % vaccine group vs. 23 % control ( p=0.0009 ) ( 6 ) . In contrary , Jackson et . large study 1378 survivor first MI , long ( median 2.3 year ) follow-up n't find benefit influenza vaccine protection recurrent coronary event ( 7 ) . The aim study evaluate influence influenza vaccination incidence cardiac event ( cardiovascular death , myocardial infarction , acute coronary syndrome , coronary revascularization hospitalization ischemia ) patient angiographically confirm coronary disease . References : 1 . Collins SD . Excess mortality cause influenza pneumonia influenza epidemic . Public Health Rep. 1932 ; 47:2159-80 . 2 . Sorlie PD , Adam E , Melnick SL , et al . Cytomegalovirus/herpesvirus carotid atherosclerosis : ARIC Study . J Med Virol . 1994 ; 42:33-37 . 3 . Zhou YF , Wanishsawad C , Epstein SE . Chlamydia pneumonia-induced transaction cytomegalovirus : potential synergy infectious agent pathogenesis atherosclerosis . J Am Coll Cardiol . 1999 ; 33 ( suppl A ) :260A . 4 . Toss H , Lindahl B , Siegbahn A , Wallentin L. ( Frisc study group ) . Prognostic Influence Increased Fibrinogen C- reactive Protein Levels Unstable Coronary Artery Disease . Circulation 1997 ; 96 : 4304- 4210 . 5 . Naghavi M. , Barlas Z. , Siadaty S. , Nagiub S. , Madjid M. , Casscells W. : Association influenza vaccination reduce risk myocardial infarction Circulation 2000 ; 102:3039-3045 . 6 . Gurfinkel E.P. , Leon de la Fuente R. , Mendiz O. , Mautner B . For FLUVACS Study Group : Influenza vaccine pilot study acute coronary syndrome plan percutaneous coronary intervention . The FLU vaccination acute coronary syndrome ( FLUVACS ) Study . Circulation 2002 ; 105:2143-2147 . 7 . Jackson L.A. , Heckbert S.R. , Psaty B.M. , Malais D. , Barlow W.E. , Thompson W.W . Vaccine Safety Datalink Study Group : Influenza vaccination associate reduction risk recurrent coronary event . Am . J. Epidemiol . 2002 ; 156 : 634-40 .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Patients , age 3080 year , CAD confirm coronarography least 50 % stenosis one large epicardial coronary artery . plan cardiovascular surgery within 6 month , congestive heart failure NYHA III/IV , evolve renal failure , neoplastic disease , psychoorganic disorder factor impede followup , contraindication vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>influenza vaccination</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>prevention</keyword>
	<keyword>acute coronary syndrome</keyword>
</DOC>